414 Clinical pharmacokinetics and pharmacodynamics of CX-4945, a novel inhibitor of protein kinase CK2: Interim report from the phase 1 clinical trial

✍ Scribed by C.S. Padgett; J.K.C. Lim; R.F. Marschke; D.W. Northfelt; E. Andreopoulou; D.D. Von Hoff; K. Anderes; D.M. Ryckman; T.K. Chen; S.E. O'Brien

• Book ID: 119603097
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 66 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72121-2